Skip to content

Immix Biopharma, Inc. IMMX Income Taxes Paid, Net

Income Taxes Paid, Net at other companies

Regenxbio logo
RegenxbioRGNX
$71.25K+496%
Xencor logo
XencorXNCR
$3.01M
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$551K+66.3%

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Immix Biopharma, Inc.’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s income taxes paid, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s income taxes paid, net?
Immix Biopharma, Inc. (IMMX) reported income taxes paid, net of $7.72K in Q3 2025.
How has Immix Biopharma, Inc.'s income taxes paid, net changed year-over-year?
Immix Biopharma, Inc.'s income taxes paid, net decreased by 30.7% year-over-year, from $11.14K to $7.72K.
What does income taxes paid, net mean?
This represents the actual cash outflow for income taxes during the period, net of any refunds received. Unlike the income tax expense reported on the income statement, this figure reflects the timing of actual tax payments to government authorities. It is a key indicator of the company's effective cash tax rate and its ability to manage tax liabilities.